Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails. (Q50925934)

http://europepmc.org/abstract/MED/23207483

25 March 2018

title

Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6354242&resulttype=core&format=json

13 May 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6354242&resulttype=core&format=json

13 May 2020

Nicholas P. Restifo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6354242&resulttype=core&format=json

13 May 2020

7

Steven A Rosenberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6354242&resulttype=core&format=json

13 May 2020

1

Shicheng Yang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6354242&resulttype=core&format=json

13 May 2020

author name string

Yun Ji

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6354242&resulttype=core&format=json

13 May 2020

Ling Zhang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6354242&resulttype=core&format=json

13 May 2020

Zhiya Yu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6354242&resulttype=core&format=json

13 May 2020

Richard A Morgan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6354242&resulttype=core&format=json

13 May 2020

publication date

4 December 2012

1 reference

http://europepmc.org/abstract/MED/23207483

25 March 2018

published in

Cancer Immunology, Immunotherapy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6354242&resulttype=core&format=json

13 May 2020

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6354242&resulttype=core&format=json

13 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6354242&resulttype=core&format=json

13 May 2020

page(s)

727-736

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6354242&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00262-012-1378-2

13 May 2020

exact match

0 references

cites work

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Lineage relationships, homeostasis, and recall capacities of central- and effector-memory CD8 T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Cancer regression in patients after transfer of genetically engineered lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Pharmacologic induction of CD8+ T cell memory: better living through chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Gamma(c) deficiency precludes CD8+ T cell memory despite formation of potent T cell effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Genetic modification of T cells with IL-21 enhances antigen presentation and generation of central memory tumor-specific cytotoxic T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

IL-7 + IL-15 are superior to IL-2 for the ex vivo expansion of 4T1 mammary carcinoma-specific T cells with greater efficacy against tumors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

IL-21 sustains CD28 expression on IL-15-activated human naive CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Phenotypic changes induced by IL-12 priming regulate effector and memory CD8 T cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Defect of CD8+ memory T cells developed in absence of IL-12 priming for secondary expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Priming of naive CD8+ T cells in the presence of IL-12 selectively enhances the survival of CD8+CD62Lhi cells and results in superior anti-tumor activity in a tolerogenic murine model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Improving adoptive T cell therapy by targeting and controlling IL-12 expression to the tumor environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Lentiviral vector design for optimal T cell receptor gene expression in the transduction of peripheral blood lymphocytes and tumor-infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Clinical-scale lentiviral vector transduction of PBL for TCR gene therapy and potential for expression in less-differentiated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

A human memory T cell subset with stem cell-like properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

A simplified method for the clinical-scale generation of central memory-like CD8+ T cells after transduction with lentiviral vectors encoding antitumor antigen T-cell receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Reprogramming of T cells from human peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Reprogramming of human peripheral blood cells to induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Paths to stemness: building the ultimate antitumour T cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1378-2

Expression of L-selectin on Th1 cells is regulated by IL-12.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23207483

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

IL-21-treated naive CD45RA+ CD8+ T cells represent a reliable source for producing leukemia-reactive cytotoxic T lymphocytes with high proliferative potential and early differentiation phenotype

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23207483

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00262-012-1378-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6354242&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6354242&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6354242&resulttype=core&format=json